Speakers from Touchstone Exploration, Shanta Gold, Savannah Resources and Kavango Resources feature in our Natural Resources webinar on May 25th. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Share News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.25
Bid: 8.25
Ask: 8.45
Change: -0.35 (-4.07%)
Spread: 0.20 (2.42%)
Open: 8.55
High: 8.55
Low: 8.25
Yest. Close: 8.60
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Proteome Sciences announces new chief executive officer

Mon, 14th Sep 2020 08:39

(Sharecast News) - Proteome Sciences announced on Monday that Dr Mariola Söhngen has been appointed as a director and its chief executive officer, taking up the position on 15 September.
The AIM-traded firm said Dr Ian Pike would remain a director of the company as chief scientific officer, having also fulfilled the role of interim CEO until Dr Söhngen's appointment.

It said Dr Söhngen had established a "strong and successful" career in the pharmaceutical industry both in the US and Europe, having been co-founder of Paion, which developed a clinical-stage asset for the treatment of stroke and subsequently delivered a novel anaesthetic that received FDA approval earlier in the year.

She was said to have been "instrumental" in the acquisition of UK-listed CeNeS Pharmaceuticals plc by Paion, and had also held roles as CEO at Mologen and Convert Pharmaceuticals.

Dr Söhngen most recently ran a pharmaceutical consultancy with a focus on supporting Chinese companies and investors trying to enter the European pharmaceuticals research and development market.

"The board is delighted to appoint Dr, Mariola Söhngen as our new CEO where she will build on the strong foundations that have already been established," said chairman Christopher Pearce.

"Mariola's time as chief medical officer at Paion, together with her international experience and network, will bring major benefits to our business as we look to engage more broadly with new and existing clients in the US, Europe and to address the rapidly-growing Asian markets."

Commenting on her appointment, Dr Söhngen said she was "very much looking forward" to working at Proteome Sciences.

"The company has established a unique position in Precision Medicine through its specialist services business and the range of 'TMT' and 'TMTpro' chemical tags sold globally by Thermo Scientific.

"I am excited to work with the board to expand commercial activities and continue to develop the corporate strategy."

Dr Söhngen said that, from her involvement in stroke at Paion, she was arriving at Proteome "highly impressed" with the quality of its technology, in particular the biomarker discovery capabilities in precision medicine and diagnostics, which were of "ever-increasing" importance and value.

"As CEO of Proteome Sciences I look forward to applying the broad experience gained from my previous interactions with a wide range of pharmaceutical companies to strengthen Proteome Sciences' position in precision medicine, and to drive shareholder value."

At 1622 BST, shares in Proteome Sciences were up 21.85% at 3.96p.

More News

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million

5 May 21 19:20

IN BRIEF: Proteome Sciences Non-Executive Roger McDowell raises stake

IN BRIEF: Proteome Sciences Non-Executive Roger McDowell raises stake

19 Apr 21 20:40

TRADING UPDATES: 4D Pharma loss widens on rise in administrative costs

TRADING UPDATES: 4D Pharma loss widens on rise in administrative costs

1 Apr 21 12:00

AIM WINNERS & LOSERS: Oilex hails milestone with Cambay resolution

AIM WINNERS & LOSERS: Oilex hails milestone with Cambay resolution

1 Apr 21 10:34

IN BRIEF: Proteome Sciences amends loan, gets extra year to pay back

IN BRIEF: Proteome Sciences amends loan, gets extra year to pay back

31 Mar 21 06:58

Proteome profit to be higher than expected thanks to royalties boost

Proteome profit to be higher than expected thanks to royalties boost

26 Mar 21 13:02

AIM WINNERS & LOSERS: Rotala skids on Burnham's Manchester bus reform

AIM WINNERS & LOSERS: Rotala skids on Burnham's Manchester bus reform

26 Mar 21 11:33

Proteome expects FY profits to be 'materially higher' than previous guidance

(Sharecast News) - Protein biomarker research and development firm Proteome Sciences said on Friday that it has been progressing with a year-end audit and now expects to announce its 2020 full-year results on 1 April.

26 Mar 21 08:37

TRADING UPDATES: IG Design Gets CSS Boost; FireAngel In Virus Hit

TRADING UPDATES: IG Design Gets CSS Boost; FireAngel In Virus Hit

25 Jan 21 16:17

Proteome Shares Rise On Appointment Of Pharma Veteran Sohngen As CEO

Proteome Shares Rise On Appointment Of Pharma Veteran Sohngen As CEO

14 Sep 20 10:35

Proteome Sciences announces new chief executive officer

(Sharecast News) - Proteome Sciences announced on Monday that Dr Mariola Söhngen has been appointed as a director and its chief executive officer, taking up the position on 15 September.

14 Sep 20 08:39

Proteome First-Half Loss Widens As Cost Rise Trumps Revenue Climb

Proteome First-Half Loss Widens As Cost Rise Trumps Revenue Climb

10 Aug 20 10:15

DIRECTOR DEALINGS: Proteome Sciences Non-Executive Ups Interest

DIRECTOR DEALINGS: Proteome Sciences Non-Executive Ups Interest

2 Jul 20 17:54

Proteome Sciences Outlook Positive; Sales Remain Stable In Five Months

Proteome Sciences Outlook Positive; Sales Remain Stable In Five Months

26 Jun 20 14:52

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

19 Jun 20 16:04

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.